Reuters reveals U.S. finds new quality problems at Lilly drug factory – Reuters News Agency


Reuters was first to report U.S. drug inspectors recently recorded several new quality-control problems at an Eli Lilly and Co plant that is already the subject of a federal investigation over manufacturing lapses, according to a government report reviewed by Reuters.

Article Tags

Topics of Interest: Health

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: North America

Countries: US

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

Source link

Leave a Comment